UK markets closed

Immunome, Inc. (IMNM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.44-0.14 (-1.11%)
At close: 04:00PM EDT
12.44 0.00 (0.00%)
After hours: 04:58PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-36,962
-106,806
-36,896
-24,711
-17,837
-
Depreciation & amortisation
489
728
631
755
755
-
Stock-based compensation
5,196
6,223
5,332
3,448
621
-
Change in working capital
2,453
11,997
2,243
2,778
-1,209
-
Accounts payable
-246
-608
-677
1,780
504
-
Other working capital
-29,002
-8,399
-28,938
-18,305
-12,720
-
Other non-cash items
-
80,802
-
4
-2
3
Net cash provided by operating activities
-28,812
-7,568
-28,690
-18,226
-12,134
-
Cash flows from investing activities
Investments in property, plant and equipment
-190
-831
-248
-79
-586
-
Purchases of investments
-
-38,929
0
-
-
-
Net cash used for investing activities
-190
-30,484
-248
-79
-586
-
Cash flows from financing activities
Debt repayment
-16
-
0
-113
-451
-612
Common stock issued
0
34
0
27,225
44,850
-
Common stock repurchased
-
-
-
-
-
-35
Other financing activities
-
-8,997
-
-781
-6,022
-35
Net cash used provided by (used for) financing activities
-163
116,408
32
27,768
49,943
-
Net change in cash
-29,165
78,356
-28,906
9,463
37,223
-
Cash at beginning of period
56,343
20,423
49,329
39,866
2,643
-
Cash at end of period
27,178
98,779
20,423
49,329
39,866
-
Free cash flow
Operating cash flow
-28,812
-7,568
-28,690
-18,226
-12,134
-
Capital expenditure
-190
-831
-248
-79
-586
-
Free cash flow
-29,002
-8,399
-28,938
-18,305
-12,720
-